Maynard Um
-
-
-
-
-
-
-
Citizens Reiterates Market Outperform Rating on Larimar Therapeutics (LRMR)
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on Larimar Therapeutics (LRMR)
-
-
-
-
-
-
-
Larimar Therapeutics announces underwritten public offering
-
-
-
-
-
-
-
Jones Trading Reiterates Buy Rating on Larimar Therapeutics (LRMR), PT $14
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Larimar Therapeutics (LRMR)
-
-
-
-
-
-
-
Larimar Therapeutics, Inc. (LRMR) Tops Q3 EPS by 13c
-
-
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

